Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Cereno Scientific AB
AB
Active
Org 5568904071
Förändringens Gata 10, 431 53
Mölndal
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2012 · 14 years old
10 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Cereno Scientific AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
SEK millions
0M
-23M
-47M
-70M
-93M
2020: -16M
-16M
2020
2021: -15M (+6% vs 2020)
-15M
+6%
2021
2022: -28M (-87% vs 2021)
-28M
-87%
2022
2023: -45M (-61% vs 2022)
-45M
-61%
2023
2024: -75M (-67% vs 2023)
-75M
-67%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−75 466
−44 711
−27 584
−15 316
−15 729
Depreciation & amort.
−287
−14
−14
−14
−14
EBIT
−75 753
−44 725
−27 598
−15 330
−15 743
Net financials
−23 690
−3 456
−149
−1 246
−272
Profit before tax
−99 443
−48 182
−27 747
−16 577
−16 015
Tax
−0
−0
−0
−0
−0
Net profit
−99 443
−48 182
−27 747
−16 577
−16 015
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
413 770
284 919
215 607
180 730
112 160
Equity
191 889
216 307
201 503
170 061
99 740
Long-term debt
190 400
45 400
400
400
400
Short-term debt
31 481
23 212
13 704
10 269
12 020
Total debt
221 881
68 612
14 104
10 669
12 420
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
46,4 %
This company
38,2 %
Market median
This company
Market median
21% above market
2020
2024
Return on equity
−51,8 %
This company
18,4 %
Market median
This company
Market median
382% below market
2020
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2020
2024
Debt / equity
1,16×
This company
0,62×
Market median
This company
Market median
87% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Cereno Scientific AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
